Biomotion Sciences-CW29SLXNWPreferred / convertible

13F holders, Q1 2026 (March 31)
19holders −3
0new positions
3sold out
$0.03avg. 13F price*

At the end of Q1 2026, 19 institutions reported holding Biomotion Sciences-CW29 (SLXNW) in their 13F filings, down 3 from Q4 2025. 0 opened new positions and 3 sold out. The largest holders were Polar Asset Management Partners Inc. ($16K), Oasis Management Co Ltd. ($14K) and Linden Advisors LP ($7K).

Company
Biomotion Sciences-CW29
Filed as
SILEXION THERAPEUTICS CORP (Q1 2026)
CUSIP
G1281K114
Latest filing quarter
Q2 2026

History

Number of 13F holders

010203040 Q3 2024: 31Q3 2024Q4 2024: 26Q4 2024Q1 2025: 25Q1 2025Q2 2025: 22Q2 2025Q3 2025: 22Q3 2025Q4 2025: 22Q4 2025Q1 2026: 19Q1 2026Q2 2026: 19Q2 2026

Total Exit/New Position Q4 2025 → Q1 2026

InstitutionsTotal Value
New Positions0$0
Exits3$378

All 13F filers, Q4 2025 → Q1 2026: 2,257 shares bought and 34,060 shares sold, net −31,803 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 19 holders

Polar Asset Management Partners Inc. — No change 743,475 $16K
Oasis Management Co Ltd. — No change 11,111 $14K
Linden Advisors LP — No change 337,500 $7K
Aristeia Capital, L.L.C. — No change 236,546 $5K
Clear Street Group Inc. — Reduce -0.1% 218,765 $4K
Goldman Sachs Group Inc. — Add +1.9% 123,494 $3K
Kepos Capital LP — No change 100,000 $2K
Security Benefit Life Insurance Co. — No change 150,000 $2K
Jane Street Group, LLC — No change 74,910 $2K
Picton Mahoney Asset Management — No change 57,175 $1K
Context Capital Management, LLC — No change 51,183 $1K
TENOR CAPITAL MANAGEMENT Co., L.P. — No change 50,000 $1K
Mint Tower Capital Management B.V. — No change 25,000 $1K
GABELLI & Co INVESTMENT ADVISERS, INC. — No change 38,150 $774
Neuberger Berman Group LLC — No change 31,552 $641
Gabelli Funds LLC — No change 30,496 $619
Dupont Capital Management Corp. — No change 32,500 $406
Stifel Financial Corp. — No change 16,000 $325
Saba Capital Management, L.P. — No change 11,937 $242

"% of holder's portfolio" is SLXNW's weight in each manager's 13F, not the share of Biomotion Sciences-CW29 the manager owns.